Sinclair Pharma PLC (LON:SPH)‘s stock had its “outperform” rating restated by Royal Bank Of Canada in a research report issued on Thursday.

Other analysts have also recently issued research reports about the company. Stifel Nicolaus lifted their target price on Sinclair Pharma PLC from GBX 49 ($0.64) to GBX 63 ($0.82) and gave the stock a “buy” rating in a research report on Wednesday, September 14th. Peel Hunt reiterated an “under review” rating on shares of Sinclair Pharma PLC in a research report on Friday, May 20th. Finally, Jefferies Group cut their target price on Sinclair Pharma PLC from GBX 60 ($0.78) to GBX 55 ($0.72) and set a “buy” rating on the stock in a research report on Wednesday, June 15th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Sinclair Pharma PLC has a consensus rating of “Buy” and a consensus target price of GBX 57 ($0.74).

Shares of Sinclair Pharma PLC (LON:SPH) traded up 0.92% during trading on Thursday, reaching GBX 27.50. The company’s stock had a trading volume of 2,033,380 shares. The company has a 50 day moving average price of GBX 29.67 and a 200 day moving average price of GBX 32.57. The firm’s market capitalization is GBX 136.67 million. Sinclair Pharma PLC has a 52 week low of GBX 26.25 and a 52 week high of GBX 61.33.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/15/sinclair-pharma-plc-sph-receives-outperform-rating-from-royal-bank-of-canada-2.html

Sinclair Pharma PLC Company Profile

Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor.

Receive News & Ratings for Sinclair Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinclair Pharma PLC and related companies with MarketBeat.com's FREE daily email newsletter.